Skip to content

Understanding Hallucinations (part II) - fMRI & EEG

Understanding Hallucinations (part II) - fMRI & EEG - Understanding Hallucinations 2

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45084
Enrollment
325
Registered
2013-10-23
Start date
2013-12-07
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Op het symptoom van hallucinaties in 6 verschillende diagnostische groepen: schizofrenie, Ziekte van Parkinson, Ziekte van Alzheimer, Lewy body dementie, patiënten die slechtziend zijn en patiënten die slechthorend zijn. Hallucinations illusory perceptional experience

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Previous participation in the phenomenology/cognition study 13-059. - Belong to one of the following diagnostic groups: 1.Patients with schizophrenia 2. Patients with Parkinson's disease 3. Patients with Lewy body dementia 4. Patients with Alzheimer's disease 5. Patients with hearing impairment 6.Patients with visual loss - Written informed consent

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
The main study endpoints are differences between hallucinating and non-hallucinating participants and between hallucinating individuals of different subtypes in: - resting state correlates as measured with fMRI, namely: connectivity within the DMN and connectivity of the DMN to sensory cortices and the hippocampal-amygdala complex. - EEG spectral analysis, synchronization likelihood, clustering index, path lengths and assortativity. - auditory and visual cortex synchronized burst activations.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)